Serum Cystatin C for Estimation of GFR
- PMID: 35939309
- PMCID: PMC12790772
- DOI: 10.1001/jama.2022.12407
Serum Cystatin C for Estimation of GFR
Erratum in
-
Error in Table.JAMA. 2022 Dec 13;328(22):2274. doi: 10.1001/jama.2022.21078. JAMA. 2022. PMID: 36511940 Free PMC article. No abstract available.
Plain language summary
An 80-year-old man with type 2 diabetes and hypertension was referred to the nephrology clinic for persistent hyperkalemia. The patient was frail and sedentary, with a BMI of 37. His estimated glomerular filtration rate calculated using creatinine was 64 mL/min/1.73 m2. How would you interpret these results?
Conflict of interest statement
Conflict of Interest Disclosures
Dr Shlipak reported receiving grants from the National Institutes of Health/National Heart, Lung, and Blood Institute/National Institute on Aging/National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study and grants from Bayer Pharmaceuticals and personal fees from Cricket Health, Intercept Pharmaceuticals, Bayer Pharmaceuticals, AstraZeneca, and Boehringer Ingelheim outside the submitted work. Dr Inker reported receiving grants from the National Institutes of Health and providing consultancy to Health Logics outside the submitted work. Dr Coresh reported consulting for Health.io during the conduct of the study and consulting for SomaLogic and receiving grants from the National Institutes of Health and National Kidney Foundation outside the submitted work.
References
-
- Inker LA, Titan S. Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021. Am J Kidney Dis. 2021;78(5):736–749. - PubMed
-
- Delgado C, Baweja M, Crews DC, et al. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis. 2022;79(2):268–288 e261. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
